These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35584002)

  • 21. Weight loss after gastric bypass surgery in women is followed by a metabolically favorable decrease in 11beta-hydroxysteroid dehydrogenase 1 expression in subcutaneous adipose tissue.
    Simonyte K; Olsson T; Näslund I; Angelhed JE; Lönn L; Mattsson C; Rask E
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3527-31. PubMed ID: 20410231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 11beta-hydroxysteroid dehydrogenase type 1 of the subcutaneous adipose tissue is dysregulated but not associated with metabolic disorders in adults born small for gestational age.
    Meas T; Carreira E; Wang Y; Rauh M; Poitou C; Clément K; Dötsch J; Lévy-Marchal C
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3949-54. PubMed ID: 20519348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal programming of metabolic syndrome in the common marmoset is associated with increased expression of 11beta-hydroxysteroid dehydrogenase type 1.
    Nyirenda MJ; Carter R; Tang JI; de Vries A; Schlumbohm C; Hillier SG; Streit F; Oellerich M; Armstrong VW; Fuchs E; Seckl JR
    Diabetes; 2009 Dec; 58(12):2873-9. PubMed ID: 19720800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of duration of critical illness and level of systemic glucocorticoid availability on tissue-specific glucocorticoid receptor expression and actions: A prospective, observational, cross-sectional human and two translational mouse studies.
    Téblick A; Van Dyck L; Van Aerde N; Van der Perre S; Pauwels L; Derese I; Debaveye Y; Wouters PJ; Vanhorebeek I; Langouche L; Van den Berghe G
    EBioMedicine; 2022 Jun; 80():104057. PubMed ID: 35584557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of regulation of 11beta-hydroxysteroid dehydrogenase type 1 during short-term manipulation of GH in patients with hypopituitarism.
    Sigurjonsdottir HA; Andrew R; Stimson RH; Johannsson G; Walker BR
    Eur J Endocrinol; 2009 Sep; 161(3):375-80. PubMed ID: 19549748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 11β-HSD1 contributes to age-related metabolic decline in male mice.
    Morgan SA; Gathercole LL; Hassan-Smith ZK; Tomlinson J; Stewart PM; Lavery GG
    J Endocrinol; 2022 Dec; 255(3):117-129. PubMed ID: 36205523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of proportions of dietary macronutrients on glucocorticoid metabolism in diet-induced obesity in rats.
    Stimson RH; Lobley GE; Maraki I; Morton NM; Andrew R; Walker BR
    PLoS One; 2010 Jan; 5(1):e8779. PubMed ID: 20098742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local and systemic glucocorticoid metabolism in inflammatory arthritis.
    Hardy R; Rabbitt EH; Filer A; Emery P; Hewison M; Stewart PM; Gittoes NJ; Buckley CD; Raza K; Cooper MS
    Ann Rheum Dis; 2008 Sep; 67(9):1204-10. PubMed ID: 18420938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role and Regulation of the 11 Beta-Hydroxysteroid Dehydrogenase Enzyme System in Patients with Inflammatory Bowel Disease.
    Hussey M; Holleran G; Smith S; Sherlock M; McNamara D
    Dig Dis Sci; 2017 Dec; 62(12):3385-3390. PubMed ID: 28932959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism.
    Draper N; Echwald SM; Lavery GG; Walker EA; Fraser R; Davies E; Sørensen TI; Astrup A; Adamski J; Hewison M; Connell JM; Pedersen O; Stewart PM
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4984-90. PubMed ID: 12414862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver-selective transgene rescue of hypothalamic-pituitary-adrenal axis dysfunction in 11beta-hydroxysteroid dehydrogenase type 1-deficient mice.
    Paterson JM; Holmes MC; Kenyon CJ; Carter R; Mullins JJ; Seckl JR
    Endocrinology; 2007 Mar; 148(3):961-6. PubMed ID: 17170103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resveratrol inhibits 11β-hydroxysteroid dehydrogenase type 1 activity in rat adipose microsomes.
    Tagawa N; Kubota S; Kato I; Kobayashi Y
    J Endocrinol; 2013 Sep; 218(3):311-20. PubMed ID: 23814014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testosterone stimulates adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in a depot-specific manner in children.
    Zhu L; Hou M; Sun B; Burén J; Zhang L; Yi J; Hernell O; Li X
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3300-8. PubMed ID: 20410225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
    Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH
    J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
    Tsilchorozidou T; Honour JW; Conway GS
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue Glucocorticoid Metabolism in Adrenal Insufficiency: A Prospective Study of Dual-release Hydrocortisone Therapy.
    Dineen RA; Martin-Grace J; Ahmed KMS; Taylor AE; Shaheen F; Schiffer L; Gilligan LC; Lavery GG; Frizelle I; Gunness A; Garrahy A; Hannon AM; Methlie P; Eystein SH; Stewart PM; Tomlinson JW; Hawley JM; Keevil BG; O'Reilly MW; Smith D; McDermott J; Healy ML; Agha A; Pazderska A; Gibney J; Behan LA; Thompson CJ; Arlt W; Sherlock M
    J Clin Endocrinol Metab; 2023 Nov; 108(12):3178-3189. PubMed ID: 37339332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue.
    Apostolova G; Schweizer RA; Balazs Z; Kostadinova RM; Odermatt A
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E957-64. PubMed ID: 15613680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy.
    Wang M
    Handb Exp Pharmacol; 2011; (203):127-46. PubMed ID: 21484570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans.
    Stimson RH; Andersson J; Andrew R; Redhead DN; Karpe F; Hayes PC; Olsson T; Walker BR
    Diabetes; 2009 Jan; 58(1):46-53. PubMed ID: 18852329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BVT.2733, a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, attenuates obesity and inflammation in diet-induced obese mice.
    Wang L; Liu J; Zhang A; Cheng P; Zhang X; Lv S; Wu L; Yu J; Di W; Zha J; Kong X; Qi H; Zhong Y; Ding G
    PLoS One; 2012; 7(7):e40056. PubMed ID: 22768329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.